97
Views
8
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Acute hormonal changes following intravenous glucose challenge in lean and obese human subjects

, , , &
Pages 275-280 | Received 11 Nov 2009, Accepted 16 Mar 2010, Published online: 29 Apr 2010
 

Abstract

Objective. To study the effects of rapid i.v. glucose bolus on insulin, leptin, ghrelin, peptide YY (PYY), free fatty acids (FFA), glucagon and glucagon-like peptide-1 (GLP-1) concentrations together with self-reported satiety ratings in lean and obese human subjects. Methods. Twenty-five healthy subjects were recruited, 12 were lean (mean age = 26 years, BMI range = 19.8–23.9 kg/m2) and 13 were obese (mean age = 27 years, BMI range = 27.7–42.2 kg/m2). In two separate 55 min counter-balanced blinded sessions (separate days), subjects were administered an i.v. dose of 300 mg/kg glucose or saline. Blood concentrations of several feeding-related hormones were recorded at multiple time points, together with ratings of satiety and euphoria. Results. Greater increases in glucose concentrations were observed in the obese group compared to the lean group (p < 0.0001). In both lean and obese subjects, glucose injection induced a clear fall in the concentrations of FFA, ghrelin, glucagon and PYY (p < 0.0001) but not in the concentrations of leptin or GLP-1. Obese subjects showed positive correlations between satiety and glucose, but only at time points 30 min (r = 0.73, p = 0.005) and 55 min (r = 0.82, p = 0.0005). Conclusions. The directions and the magnitudes of short-term hormonal changes after i.v. glucose challenge are the same in lean and moderately obese subjects. Possible short-term regulatory effects of leptin and GLP-1 can not be induced by acute energy load bypassing the GI-tract.

Acknowledgements

We wish to thank the staff of the Turku PET Centre for their skilled assistance in the examinations. Raija Kaartosalmi is acknowledged for carrying out the hormonal assays. This study was financially supported by the Academy of Finland (decision number 104334), the Turku University Central Hospital (EVO), the Turku University Foundation and the Research Foundation of Orion Corporation.

Declaration of interest: The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.